Mueller Brian
Insider CIK 1514980 · BMRN VP, Corporate Controller · ANTH Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2026-03-17 | 2026-03-19 | 2,117 | $56.05 | $118.7K | 123,314 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2026-03-16 | 2026-03-17 | 44,600 | — | $0 | 44,600 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2026-03-16 | 2026-03-17 | 18,740 | — | $0 | 125,431 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2026-03-13 | 2026-03-17 | 9,945 | $58.51 | $581.9K | 106,691 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2026-02-25 | 2026-02-26 | 6,683 | — | $0 | 106,839 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2026-02-25 | 2026-02-26 | 7,230 | — | $0 | 114,069 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2026-02-25 | 2026-02-26 | 2,569 | — | $0 | 116,638 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2025-03-17 | 2025-03-18 | 38,590 | — | $0 | 38,590 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2025-03-17 | 2025-03-18 | 16,640 | — | $0 | 99,781 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2025-03-14 | 2025-03-18 | 18,497 | $69.44 | $1.28M | 83,141 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2025-02-25 | 2025-02-27 | 9,660 | — | $0 | 92,271 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2025-02-25 | 2025-02-27 | 9,367 | — | $0 | 101,638 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2025-02-25 | 2025-02-27 | 11,040 | — | $0 | 82,611 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2024-06-28 | 2024-07-01 | 588 | $82.33 | $48.4K | 71,571 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2024-05-30 | 2024-05-31 | 5,000 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2024-05-30 | 2024-05-31 | 5,000 | $63.10 | $315.5K | 77,159 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-05-30 | 2024-05-31 | 5,000 | $75.19 | $375.9K | 72,159 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-04-30 | 2024-05-31 | 300 | $68.65 | $20.6K | 72,159 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2024-03-15 | 2024-03-19 | 25,540 | — | $0 | 25,540 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2024-03-15 | 2024-03-19 | 20,789 | $83.87 | $1.74M | 71,859 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-03-15 | 2024-03-19 | 11,400 | — | $0 | 92,648 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-02-27 | 2024-02-29 | 6,103 | — | $0 | 81,248 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-02-27 | 2024-02-29 | 20,220 | — | $0 | 66,343 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-02-27 | 2024-02-29 | 8,802 | — | $0 | 75,145 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2023-06-29 | 2023-06-30 | 576 | $88.93 | $51.2K | 45,805 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2023-06-29 | 2023-06-30 | 4,602 | $88.93 | $409.3K | 46,381 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2023-06-29 | 2023-06-30 | 4,602 | $88.93 | $409.3K | 50,983 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2023-03-16 | 2023-03-17 | 3,973 | $93.41 | $371.1K | 55,585 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2023-03-15 | 2023-03-17 | 21,970 | — | $0 | 21,970 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2023-03-15 | 2023-03-17 | 2,708 | $87.74 | $237.6K | 59,558 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-03-15 | 2023-03-17 | 9,630 | — | $0 | 62,266 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-02-28 | 2023-03-02 | 12,660 | — | $0 | 40,406 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-02-28 | 2023-03-02 | 1,250 | — | $0 | 52,636 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-02-28 | 2023-03-02 | 10,980 | — | $0 | 51,386 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2023-01-13 | 2023-01-17 | 2,500 | — | $0 | 5,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2023-01-13 | 2023-01-17 | 2,500 | $63.10 | $157.8K | 30,246 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-01-13 | 2023-01-17 | 2,500 | $114.50 | $286.3K | 27,746 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-12-13 | 2022-12-15 | 2,500 | — | $0 | 7,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-12-13 | 2022-12-15 | 2,500 | $63.10 | $157.8K | 30,246 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-12-13 | 2022-12-15 | 2,500 | $107.50 | $268.8K | 27,746 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-12-02 | 2022-12-06 | 3,761 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-12-02 | 2022-12-06 | 2,139 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-12-02 | 2022-12-06 | 2,139 | $67.81 | $145.0K | 29,885 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-12-02 | 2022-12-06 | 3,761 | $67.81 | $255.0K | 31,507 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-12-02 | 2022-12-06 | 2,139 | $104.50 | $223.5K | 27,746 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-12-02 | 2022-12-06 | 1,101 | $104.50 | $115.1K | 27,746 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-12-02 | 2022-12-06 | 3,761 | $104.50 | $393.0K | 27,746 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-11-23 | 2022-11-28 | 3,500 | — | $0 | 3,761 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-11-23 | 2022-11-28 | 934 | $95.09 | $88.8K | 29,792 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-11-23 | 2022-11-28 | 945 | $99.50 | $94.0K | 28,847 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-11-23 | 2022-11-28 | 3,500 | $99.50 | $348.3K | 28,847 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-11-23 | 2022-11-28 | 3,500 | $67.81 | $237.3K | 32,347 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-08-05 | 2022-08-09 | 3,500 | — | $0 | 7,261 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-08-05 | 2022-08-09 | 3,500 | $67.81 | $237.3K | 34,226 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-08-05 | 2022-08-09 | 3,500 | $94.50 | $330.8K | 30,726 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-07-08 | 2022-07-12 | 7,337 | $89.50 | $656.7K | 30,726 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2022-06-29 | 2022-07-01 | 576 | $83.92 | $48.3K | 38,063 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-05-04 | 2022-05-06 | 2,038 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-05-04 | 2022-05-06 | 9,762 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-05-04 | 2022-05-06 | 2,038 | $84.50 | $172.2K | 38,639 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-05-04 | 2022-05-06 | 9,762 | $37.46 | $365.7K | 48,401 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-05-04 | 2022-05-06 | 9,762 | $84.50 | $824.9K | 38,639 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-05-04 | 2022-05-06 | 2,038 | $37.46 | $76.3K | 40,677 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2022-04-29 | 2022-05-06 | 340 | $62.41 | $21.2K | 38,639 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2022-03-16 | 2022-03-17 | 582 | $80.72 | $47.0K | 38,299 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2022-03-15 | 2022-03-17 | 26,520 | — | $0 | 26,520 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2022-03-15 | 2022-03-17 | 1,868 | $78.27 | $146.2K | 38,881 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2022-03-15 | 2022-03-17 | 11,040 | — | $0 | 40,749 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2022-02-03 | 2022-02-07 | 1,072 | $87.77 | $94.1K | 29,709 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2021-06-29 | 2021-06-30 | 576 | $83.46 | $48.1K | 30,781 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-05-07 | 2021-05-11 | 6,709 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-05-07 | 2021-05-11 | 6,709 | $79.50 | $533.4K | 31,357 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-05-07 | 2021-05-11 | 6,709 | $28.23 | $189.4K | 38,066 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2021-04-30 | 2021-05-11 | 341 | $62.41 | $21.3K | 31,357 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-04-01 | 2021-04-02 | 5,692 | $76.30 | $434.3K | 31,016 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2021-03-22 | 2021-03-23 | 516 | $78.52 | $40.5K | 36,708 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2021-03-16 | 2021-03-17 | 582 | $77.21 | $44.9K | 37,224 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2021-03-15 | 2021-03-17 | 24,890 | — | $0 | 24,890 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2021-03-15 | 2021-03-17 | 10,110 | — | $0 | 38,800 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2021-03-15 | 2021-03-17 | 994 | $78.39 | $77.9K | 37,806 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2021-02-03 | 2021-02-04 | 1,071 | $82.82 | $88.7K | 28,673 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2020-06-29 | 2020-06-30 | 13,230 | — | $0 | 13,230 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2020-06-29 | 2020-06-30 | 4,640 | — | $0 | 29,744 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2020-04-30 | 2020-06-30 | 323 | $62.59 | $20.2K | 25,104 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2020-03-20 | 2020-03-24 | 414 | $73.05 | $30.2K | 24,781 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2020-03-16 | 2020-03-17 | 9,600 | — | $0 | 9,600 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2020-03-16 | 2020-03-17 | 6,730 | — | $0 | 25,195 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2020-03-13 | 2020-03-17 | 1,303 | $84.50 | $110.1K | 18,465 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2020-02-03 | 2020-02-04 | 5,800 | — | $0 | 19,768 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2019-10-31 | 2020-02-04 | 9 | $62.23 | $560 | 13,968 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2019-04-30 | 2019-06-07 | 299 | $68.78 | $20.6K | 13,959 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2019-04-05 | 2019-04-09 | 2,953 | $94.00 | $277.6K | 13,660 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2019-03-22 | 2019-03-26 | 415 | $88.05 | $36.5K | 16,613 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2019-03-15 | 2019-03-19 | 9,650 | — | $0 | 9,650 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2019-03-15 | 2019-03-19 | 1,149 | $94.53 | $108.6K | 11,248 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2019-03-15 | 2019-03-19 | 5,780 | — | $0 | 17,028 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-10-31 | 2018-12-20 | 22 | $68.78 | $1.5K | 12,397 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2018-08-07 | 2018-08-09 | 1,718 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2018-08-07 | 2018-08-09 | 782 | — | $0 | 6,709 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2018-08-07 | 2018-08-09 | 782 | $28.23 | $22.1K | 14,875 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-08-07 | 2018-08-09 | 2,500 | $104.50 | $261.3K | 12,375 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2018-08-07 | 2018-08-09 | 1,718 | $28.23 | $48.5K | 14,093 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2018-06-22 | 2018-06-26 | 2,491 | — | $0 | 1,718 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2018-06-22 | 2018-06-26 | 2,491 | $28.23 | $70.3K | 14,866 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-06-22 | 2018-06-26 | 2,491 | $99.50 | $247.9K | 12,375 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-06-22 | 2018-06-26 | 654 | $99.50 | $65.1K | 12,375 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-06-15 | 2018-06-18 | 2,021 | $94.50 | $191.0K | 13,029 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-06-04 | 2018-06-06 | 346 | $92.07 | $31.9K | 15,050 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-05-10 | 2018-05-14 | 2,450 | $89.50 | $219.3K | 15,396 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-04-30 | 2018-05-14 | 287 | $68.78 | $19.7K | 17,846 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-03-22 | 2018-03-26 | 414 | $81.36 | $33.7K | 17,559 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-03-16 | 2018-03-20 | 346 | $84.10 | $29.1K | 12,263 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2018-03-15 | 2018-03-20 | 9,120 | — | $0 | 9,120 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-03-15 | 2018-03-20 | 5,710 | — | $0 | 17,973 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-03-15 | 2018-03-20 | 309 | $83.57 | $25.8K | 12,609 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2018-01-05 | 2018-01-09 | 84,705 | — | $0 | 84,705 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2018-01-05 | 2018-01-09 | 84,705 | — | $0 | 84,705 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-06-22 | 2017-06-23 | 2,671 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-06-22 | 2017-06-23 | 2,671 | $100.00 | $267.1K | 12,885 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-06-22 | 2017-06-23 | 2,671 | $21.51 | $57.5K | 15,556 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2017-06-02 | 2017-06-06 | 376 | $90.72 | $34.1K | 12,885 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2017-05-15 | 2017-05-17 | 207 | $91.50 | $18.9K | 13,261 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-05-08 | 2017-05-10 | 2,600 | — | $0 | 2,671 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-05-08 | 2017-05-10 | 4,882 | $91.17 | $445.1K | 13,468 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-05-08 | 2017-05-10 | 2,600 | $21.51 | $55.9K | 16,068 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-05-08 | 2017-05-10 | 2,600 | $93.17 | $242.2K | 13,468 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2017-04-28 | 2017-05-10 | 270 | $70.30 | $19.0K | 18,350 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2017-03-22 | 2017-03-24 | 7,740 | — | $0 | 7,740 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2017-03-22 | 2017-03-24 | 4,790 | — | $0 | 18,080 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2017-03-16 | 2017-03-17 | 376 | $90.96 | $34.2K | 13,290 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2017-03-15 | 2017-03-17 | 336 | $92.50 | $31.1K | 13,666 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-08-01 | 2016-08-03 | 287 | $100.00 | $28.7K | 14,260 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-06-03 | 2016-06-07 | 376 | $90.00 | $33.8K | 14,547 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-05-13 | 2016-05-17 | 207 | $82.71 | $17.1K | 14,923 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-05-06 | 2016-05-10 | 444 | $80.80 | $35.9K | 15,130 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-04-29 | 2016-05-10 | 327 | $51.26 | $16.8K | 15,574 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2016-04-27 | 2016-04-29 | 41,379 | — | $0 | 41,379 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-03-16 | 2016-03-17 | 376 | $80.34 | $30.2K | 15,247 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2016-03-15 | 2016-03-17 | 7,000 | — | $0 | 7,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-03-15 | 2016-03-17 | 3,570 | — | $0 | 15,623 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | M Exercise | 2015-12-23 | 2015-12-24 | 10,000 | $2.89 | $28.9K | 10,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2015-06-04 | 2015-06-08 | 522 | $120.46 | $62.9K | 11,926 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2015-05-31 | 2015-06-03 | 308 | $125.57 | $38.7K | 12,448 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2015-05-21 | 2015-05-22 | 28,846 | — | $0 | 28,846 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2015-05-15 | 2015-05-19 | 207 | $122.78 | $25.4K | 12,756 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2015-05-08 | 2015-05-12 | 444 | $121.66 | $54.0K | 12,963 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2015-04-30 | 2015-05-12 | 607 | $51.26 | $31.1K | 13,407 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2015-03-16 | 2015-03-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2015-03-16 | 2015-03-17 | 4,000 | — | $0 | 12,800 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-03-03 | 2015-03-05 | 7,000 | $109.46 | $766.2K | 8,800 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2015-03-03 | 2015-03-05 | 7,000 | $28.23 | $197.6K | 15,800 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2014-12-30 | 2015-01-02 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2014-12-02 | 2015-03-05 | 7,000 | — | $0 | 7,491 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2014-12-02 | 2014-12-03 | 5,000 | — | $0 | 14,491 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2014-12-02 | 2014-12-03 | 5,000 | $28.23 | $141.2K | 9,593 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-12-02 | 2014-12-03 | 5,000 | $91.82 | $459.1K | 4,593 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2014-12-01 | 2014-12-03 | 521 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2014-12-01 | 2014-12-03 | 6,429 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-12-01 | 2014-12-03 | 6,950 | $90.25 | $627.2K | 4,593 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2014-12-01 | 2014-12-03 | 521 | $14.39 | $7.5K | 5,114 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2014-12-01 | 2014-12-03 | 6,429 | $21.51 | $138.3K | 11,543 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-11-26 | 2014-12-02 | 3,400 | $88.97 | $302.5K | 4,593 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | M Exercise deriv | 2014-07-29 | 2015-12-24 | 10,000 | — | $0 | 2,500 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2014-07-29 | 2014-08-04 | 18,750 | — | $0 | 18,750 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2014-07-29 | 2014-08-04 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2014-06-04 | 2015-03-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-06-04 | 2015-03-05 | 4,000 | — | $0 | 8,800 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2014-05-31 | 2014-06-03 | 297 | $57.96 | $17.2K | 7,993 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2014-05-15 | 2014-05-16 | 207 | $57.44 | $11.9K | 8,290 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2014-05-12 | 2014-05-14 | 282 | $59.30 | $16.7K | 8,497 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2014-05-08 | 2014-05-12 | 444 | $56.78 | $25.2K | 8,281 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-04-30 | 2014-05-12 | 498 | $29.69 | $14.8K | 8,779 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2013-05-31 | 2013-06-04 | 413 | $62.70 | $25.9K | 8,447 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2013-05-15 | 2013-05-17 | 12,900 | — | $0 | 12,900 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-05-15 | 2013-05-17 | 2,200 | — | $0 | 8,860 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-05-14 | 2013-05-15 | 3,500 | $21.51 | $75.3K | 6,429 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-05-14 | 2013-05-15 | 1,447 | $70.41 | $101.9K | 6,660 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-05-14 | 2013-05-15 | 3,500 | $21.51 | $75.3K | 10,160 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-05-14 | 2013-05-15 | 3,500 | $70.33 | $246.2K | 6,660 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2013-05-12 | 2013-05-14 | 817 | $67.68 | $55.3K | 8,107 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2013-05-08 | 2013-05-14 | 479 | $65.32 | $31.3K | 8,924 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-05-03 | 2013-05-06 | 4,874 | — | $0 | 521 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-05-03 | 2013-05-06 | 7,500 | $67.11 | $503.3K | 9,403 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-05-03 | 2013-05-06 | 7,500 | $21.51 | $161.3K | 16,903 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-05-02 | 2013-05-06 | 7,500 | — | $0 | 15,200 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-05-02 | 2013-05-06 | 4,457 | $65.48 | $291.8K | 9,403 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-05-02 | 2013-05-06 | 4,874 | $14.39 | $70.1K | 18,734 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-05-02 | 2013-05-06 | 4,874 | $65.35 | $318.5K | 13,860 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-04-30 | 2013-05-06 | 581 | $23.21 | $13.5K | 13,860 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-03-01 | 2013-03-04 | 730 | — | $0 | 67,200 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-03-01 | 2013-03-04 | 3,605 | — | $0 | 63,595 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-03-01 | 2013-03-04 | 688 | — | $0 | 67,930 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-03-01 | 2013-03-04 | 2,015 | $59.81 | $120.5K | 13,279 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-03-01 | 2013-03-04 | 5,023 | $59.74 | $300.1K | 15,294 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-03-01 | 2013-03-04 | 3,605 | $14.39 | $51.9K | 20,317 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-03-01 | 2013-03-04 | 730 | $17.86 | $13.0K | 16,712 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-03-01 | 2013-03-04 | 688 | $38.59 | $26.5K | 15,982 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-11-15 | 2012-11-19 | 5,500 | — | $0 | 78,930 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-11-15 | 2012-11-19 | 10,312 | — | $0 | 68,618 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-11-15 | 2012-11-19 | 5,500 | $14.39 | $79.1K | 20,840 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-11-15 | 2012-11-19 | 10,312 | $38.59 | $397.9K | 31,152 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-11-15 | 2012-11-19 | 15,812 | $50.00 | $790.6K | 15,340 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-11-05 | 2012-11-07 | 8,000 | — | $0 | 84,430 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-11-05 | 2012-11-07 | 8,000 | $14.39 | $115.1K | 23,340 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-11-05 | 2012-11-07 | 5,500 | $47.50 | $261.3K | 15,340 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-11-05 | 2012-11-07 | 2,500 | $46.00 | $115.0K | 20,840 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-07-10 | 2012-07-11 | 2,500 | — | $0 | 92,430 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-07-10 | 2012-07-11 | 2,500 | $14.39 | $36.0K | 17,840 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-07-10 | 2012-07-11 | 2,500 | $42.50 | $106.3K | 15,340 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-07-02 | 2012-07-05 | 2,770 | — | $0 | 94,930 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-07-02 | 2012-07-05 | 2,770 | $17.86 | $49.5K | 18,110 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-07-02 | 2012-07-05 | 2,770 | $40.00 | $110.8K | 15,340 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-05-22 | 2012-05-23 | 150 | — | $0 | 2,462 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2012-05-22 | 2012-05-23 | 56 | $37.98 | $2.1K | 15,340 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-05-22 | 2012-05-23 | 150 | — | $0 | 15,396 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-05-12 | 2012-05-14 | 750 | — | $0 | 2,612 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-05-12 | 2012-05-14 | 812 | — | $0 | 3,362 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-05-12 | 2012-05-14 | 812 | — | $0 | 14,496 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-05-12 | 2012-05-14 | 750 | — | $0 | 15,246 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2012-05-08 | 2012-05-10 | 11,800 | — | $0 | 113,408 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-05-08 | 2012-05-10 | 10,000 | — | $0 | 103,408 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-05-08 | 2012-05-10 | 417 | — | $0 | 102,991 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-05-08 | 2012-05-10 | 4,291 | — | $0 | 98,700 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-05-08 | 2012-05-10 | 675 | $37.50 | $25.3K | 98,025 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-05-08 | 2012-05-10 | 375 | — | $0 | 97,650 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-05-08 | 2012-05-11 | 625 | $37.50 | $23.4K | 98,075 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-05-08 | 2012-05-11 | 375 | — | $0 | 97,700 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2012-05-08 | 2012-05-11 | 11,800 | — | $0 | 113,408 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-05-08 | 2012-05-11 | 10,000 | — | $0 | 103,408 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-05-08 | 2012-05-11 | 4,291 | — | $0 | 98,700 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-05-08 | 2012-05-11 | 417 | — | $0 | 102,991 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-05-08 | 2012-05-10 | 625 | $17.89 | $11.2K | 29,017 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-05-08 | 2012-05-10 | 4,291 | $17.33 | $74.4K | 28,392 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-05-08 | 2012-05-10 | 417 | $17.54 | $7.3K | 24,101 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-05-08 | 2012-05-10 | 10,000 | $11.74 | $117.4K | 23,684 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2012-05-08 | 2012-05-10 | 4,720 | — | $0 | 13,684 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-05-08 | 2012-05-10 | 15,708 | $37.50 | $589.0K | 13,684 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-05-08 | 2012-05-10 | 375 | $17.89 | $6.7K | 29,392 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-05-08 | 2012-05-11 | 15,708 | $37.50 | $589.0K | 13,684 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-05-08 | 2012-05-11 | 375 | $17.89 | $6.7K | 29,392 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-05-08 | 2012-05-11 | 625 | $17.89 | $11.2K | 29,017 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-05-08 | 2012-05-11 | 4,291 | $17.33 | $74.4K | 28,392 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-05-08 | 2012-05-11 | 417 | $17.54 | $7.3K | 24,101 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-05-08 | 2012-05-11 | 10,000 | $11.74 | $117.4K | 23,684 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2012-05-08 | 2012-05-11 | 4,720 | — | $0 | 13,684 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2012-04-30 | 2012-05-10 | 664 | $19.35 | $12.8K | 8,964 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2012-04-30 | 2012-05-11 | 664 | $19.35 | $12.8K | 8,964 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-02-24 | 2012-02-28 | 5,000 | — | $0 | 101,608 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-02-24 | 2012-02-28 | 5,000 | $35.07 | $175.3K | 8,300 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-02-24 | 2012-02-28 | 5,000 | $11.74 | $58.7K | 13,300 | SEC↗ |